Media.Player

Uses of dl-THP

總結

dl-THP (dl-tetrahydropalinatine) was only marketed as an herbal supplement or sleeping pill. However, a novel use of dl-THP is available now.

The present invention succeeds in identifying a previously unsuggested binding partner for dl-THP, namely the BDZ (benzodiazepine) binding site of the GABAA receptor. A method of manufacture of a composition (eg. A medicament) for the treatment of CNS (central nervous system) disorders, including the treatment of anxiety and seizures, the composition comprising dl-THP is provided.

Thus, the uses of dl-THP could be expanded and developed into sedative-tranquilizing, anticonvulsant or myorelaxant agents for the treatment of CNS disorders.

技術優勢

1. New usage of dl-THP
2. Low toxicity

技術應用

- Potential drugs for the treatment of central nervous system disorders or memory impairment
- Potential anxiolytic, anti-convulsantor sedative-hypustic drugs

附加資料

Patent Number: US6521634B2
Application Number: US2001819367A
Inventor: Xue, Hong | Law, Sek Lun
Priority Date: 28 Mar 2001
Priority Number: US6521634B2
Application Date: 28 Mar 2001
Publication Date: 18 Feb 2003
IPC Current: A61K003146 | A61K00314745 | A61P002508 | A61P002522
US Class: 514284
Assignee Applicant: The Hong Kong University of Science & Technology
Title: Uses of dl-THP
Usefulness: Uses of dl-THP
Summary: The method is useful for treating CNS disorders, especially anxiety, seizures, status epilepticus, cerebral palsy and generalized anxiety disorder. It is also useful for achieving an anticonvulsant or anesthetic premedicative effect (claimed).
Novelty: Treatment of central nervous system disorders e.g. anxiety, seizure, status epilepticus, cerebral palsy and generalized anxiety disorder, comprising administration of dl-tetrahydropalmatine

主要類別

診斷/治療

細分類別

其他疾病

申請日期

28 Mar 2001

申請號碼

US 09/819367

專利信息

US 6521634

ID號碼

TTC.PA.122

國家/地區

香港